Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.9200 (2.99%) ($7.5600 - $7.9600) on Thu. Apr. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.41% (three month average) | RSI | 50 | Latest Price | $7.9200(2.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLC(4%) VXX(3%) BLOK(2%) IBB(2%) TBT(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.705% in a week (0% probabilities). SLV(-11%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.705% (StdDev 3.41%) | Hourly BBV | 0 () | Intraday Trend | 2.7% | | | |
|
Resistance Level | $8.27 | 5 Day Moving Average | $8.18(-3.18%) | 10 Day Moving Average | $8.41(-5.83%) | 20 Day Moving Average | $8.27(-4.23%) | To recent high | -18.5% | To recent low | 7.3% | Market Cap | $1.397b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |